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RESUMO
O exame de fundo de olho para o diagnós-
tico precoce da retinopatia da prematuri-
dade causa dor no prematuro, sendo ne-
cessárias intervenções que a minimizem. O 
objetivo foi investigar a efetividade do leite 
humano para alívio da dor em prematuros 
submetidos ao exame de fundo de olho 
para diagnóstico precoce da doença, em 
comparação com a sacarose. Tratou-se de 
um estudo piloto de caráter quase experi-
mental, realizado com 14 prematuros in-
ternados na unidade neonatal de um hos-
pital universitário. Na comparação entre os 
grupos, não houve diferença estatística sig-
nificativa relacionada à duração do tempo 
de choro, concentração do cortisol salivar 
e frequência cardíaca. O leite humano pa-
rece ser tão efetivo quanto a sacarose no 
alívio da dor aguda relacionada ao exame. 
Tem-se como limitação o tamanhoreduzi-
do da amostra e a falta de randomização. 
É necessária a realização de estudos expe-
rimentais com maior poder amostral para 
fortalecer as evidências encontradas.
DESCRITORES 
Dor
Prematuro
Leite humano
Retinopatia da prematuridade
Enfermagem materno-infantil
Human milk for neonatal pain relief during 
ophthalmoscopy*
O
r
ig
in
a
l a
r
t
ic
l
e
ABSTRACT
Ophthalmoscopy performed for the early 
diagnosis of retinopathy of prematurity 
(ROP) is painful for preterm infants, thus 
necessitating interventions for minimizing 
pain. The present study aimed to establish 
the effectiveness of human milk, compared 
with sucrose, for pain relief in premature 
infants subjected to ophthalmoscopy for 
the early diagnosis of ROP. This investiga-
tion was a pilot, quasi-experimental study 
conducted with 14 premature infants ad-
mitted to the neonatal intensive care unit 
(NICU) of a university hospital. Comparison 
between the groups did not yield a statis-
tically significant difference relative to the 
crying time, salivary cortisol, or heart rate 
(HR). Human milk appears to be as effec-
tive as sucrose in relieving acute pain as-
sociated with ophthalmoscopy. The study’s 
limitations included its small sample size 
and lack of randomization. Experimental 
investigations with greater sample power 
should be performed to reinforce the evi-
dence found in the present study. 
DESCRIPTORS 
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RESUMEN 
El examen de fondo de ojo para el diagnós-
tico precoz de retinopatía prematura causa 
dolor en el prematuro, siendo necesarias 
intervenciones que la minimicen. El objeti-
vo fue investigar la efectividad de la leche 
humana para el alivio del dolor en los pre-
maturos sometidos al examen de fondo de 
ojo para el diagnóstico precoz de la enfer-
medad, en comparación con la sacarosa. Es-
tudio piloto de carácter cuasi-experimental, 
realizado con 14 prematuros internados en 
la unidad neonatal de un hospital universita-
rio. En la comparación entre los grupos, no 
hubo diferencia estadística significativa rela-
cionada a la duración del tiempo del llanto, 
la concentración del cortisol salival y la fre-
cuencia cardiaca. La leche humana parece 
ser tan efectiva como la sacarosa en el alivio 
del dolor agudo debido al examen. Una limi-
tación fue el reducido tamaño de la muestra 
y la falta de aleatorización. Es necesaria la 
realización de estudios experimentales con 
mayor tamaño de muestra para fortalecer 
las evidencias encontradas.      
DESCRIPTORES 
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INTRODUCTION
The diagnosis of retinopathy of prematurity (ROP) is 
performed via ophthalmoscopy. ROP involves abnormal 
development of the retinal blood vessels and occurs du-
ring the first days of life in premature infants(1). In Latin 
America and the Caribbean, approximately 42,000 infants 
with birth weights less than 1,500 grams require screening 
for ROP every year, and 4,300 require treatment. When 
ROP is not treated, or if treatment is inadequate, 50% of 
the affected infants might become blind(1).
Brazil ranks 72nd relative to the international preva-
lence of ROP, which was estimated as 14.2% in 2004(2). 
Ophthalmoscopy is one of the most commonly performed 
procedures in neonatal intensive care units (NICUs), and 
although painful, it is crucial to prevent visual impair-
ments that might progress into blindness(3).
Pain triggers compensatory mechanisms involving the 
autonomous nervous system, causing changes in the he-
art rate (HR), respiratory rate (RR), arterial pressure, and 
oxygen saturation (SatO
2
), as well as pe-
ripheral vasoconstriction, sweating, pupil 
dilation, and increased release of catecho-
lamines and adrenocorticosteroids(4-5). In 
addition to the physiological changes, beha-
vioral responses occur, such as crying, chan-
ges in facial expression, and altered sleep/
wake patterns(6).
Among the methods investigated to redu-
ce the pain associated with ophthalmoscopy 
in premature infants, a systematic review in-
cluded the use of topical anesthetics, sucro-
se, developmental care, and the Newborn 
Individualized Care and Assessment Program 
– NIDCAP(7). Instillation of one or two drops of 5% propara-
caine in the conjunctival sac was found to reduce the scores 
on the Premature Infant Pain Profile (PIPP) by 2.5 compared 
with saline solution; however, in another study, neither the 
physiological indicators (i.e., HR, RR, or systolic and diastolic 
indexes) nor crying exhibited significant differences compa-
red with saline solution. Developmental care (non-nutritive 
sucking + 24% sucrose + facilitated tucking + holding the 
baby in the arms) and the NIDCAP did not shorten the time 
necessary for the vital signs to return to the baseline, nor did 
these methods reduce the PIPP scores compared with no 
treatment; however, the salivary cortisol before and after 
ophthalmoscopy was lower in the premature infants subjec-
ted to the NIDCAP (p=0.017). Oral sucrose at a concentration 
of 24% to 33% in single (0.12 ml to 2 ml) or repeated doses 
(three 0.1-ml doses), either combined or not combined with 
non-nutritive suction, reduced the average PIPP score (95% 
confidence interval (CI)=0.41/2.35) by 1.8 compared with 
distilled water, normal saline solution, and facilitated tucking 
or holding the baby (p=0.005). The authors of the above-
mentioned systematic review concluded that the PIPP scores 
remained high during ophthalmoscopy (average score=10.5, 
with a score ≥6 indicating the presence of pain) and empha-
sized the necessity to investigate other analgesic methods(7).
Nonetheless, regarding sucrose, a study(8) not inclu-
ded in the abovementioned review analyzed the analgesic 
effect of 0.2 ml of 24% sucrose combined with the use of 
a pacifier and facilitated tucking. Treatment with sucrose 
was associated with lower scores on the Neonatal Pain 
Agitation and Sedation Scale (N-PASS) during ophthalmos-
copy soon after speculum insertion (6.5 vs. 5; p=0.02) and 
during scleral manipulation (9.5 vs. 7.5; p=0.03) compared 
with placebo (distilled water administered orally). In addi-
tion, the premature infants who were given sucrose exhi-
bited a lower percentage of side effects, such decreased 
SatO2 and bradycardia (1 vs. 4; p=0.18)(8).
Because of the inconsistent results yielded by the abo-
vementioned methods to reduce pain during ophthalmos-
copy in premature infants, other types of interventions 
should be investigated. In addition, the long-term effects 
of the repeated use of sucrose on the children’s develop-
ment are not known(9).
Human milk is proven to have analgesic 
properties in procedures such as heel and 
vein punctures(10); however, human milk has 
not yet been tested for ophthalmoscopy. 
Thus, we questioned whether human milk 
might also be effective in reducing the acu-
te pain associated with ophthalmoscopy in 
premature infants. 
A further motive behind the present 
study is the fact that human milk is natural 
and affords countless benefits to prema-
ture infants(10). Its use is further justified 
within the context of the strategies to sti-
mulate breastfeeding, which are aimed at better mother-
and-child care(11). 
We chose sucrose instead of a placebo (distilled water) 
as the control because the use of sucrose is currently re-
commended as a method to minimize acute pain(12-13). In 
addition, children have the right not to experience pain, 
as established by the Children and Adolescent’s Rights in 
the Hospital (Direitos da Criança e do Adolescente Hospi-
talizados)(14) and the Universal Declaration of Premature 
Babies’ Rights (Declaração Universal dos Direitos do Be-
bê Prematuro)(15). Consequently, based on the current re-
commendations for acute neonatal pain relief, the proper 
pain treatment was granted to all the premature infants 
who participated in the present study.
The aim of the present study was to compare the 
effectiveness of human milk vs. 25% sucrose in premature 
infants subjected to ophthalmoscopy for the early diag-
nosis of ROP. The underlying hypothesis was that human 
milk is as effective as sucrose for relieving acute pain in 
premature infants subjected to ROP ophthalmoscopy.
Human milk is 
proven to have 
analgesic properties 
in procedures such 
as heel and vein 
punctures; however, 
human milk has not 
yet been tested for 
ophthalmoscopy.
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METHOD
The present investigation was a pilot study with a 
quasi-experimental design as it involved one independent 
variable (human milk) but did not comply with the rando-
mization criteria typical of true experiments(16).
In the present study, the intervention group (IG) was 
given human milk from a milk bank because many pre-
mature infants are immature and have difficulty sucking 
efficiently at their mothers’ breast, and the mothers often 
exhibit deficient milk secretion. The control group (CG) 
was orally administered 25% sucrose (0.5 ml/Kg) 2 minu-
tes before ophthalmoscopy according to the institutional 
protocol for acute neonatal pain relief. Immediately befo-
re the eye exam, the ophthalmologist instilled one drop 
of the anesthetic collyrium (proxymetacaine) in each eye 
of all the participants. In addition, all the participants un-
derwent facilitated tucking during the eye exam.
The study was conducted in the NICU of the Clinical 
Hospital, Ribeirão Preto School of Medicine – University of 
São Paulo (Hospital das Clínicas da Faculdade de Medicina 
de Ribeirão Preto-USP/HCFMRP-USP), which is a tertiary 
reference center for perinatal care, from November 2010 
to May 2011. The study was approved by the hospital’s 
research ethics committee (process no. 1127/2010). The 
participants’ anonymity was ensured, and the infants’ 
mothers and/or guardians (in the case of adolescent mo-
thers) signed an informed consent form.
The convenience sample included 14 premature in-
fants, who were given sucrose (n=9) or human milk (n=5), 
provided they met the following inclusion criteria: gesta-
tional age (GA) ≤32 weeks and 6 days, birth weight ≤1,500 
grams, first ophthalmoscopy scheduled for the fourth to 
sixth week of life, clinical stability with the physiological 
parameters within the normal range before the test, and 
at least one hour since the last feeding. Premature infants 
under assisted ventilation; with grade III or IV intraventri-
cular hemorrhage or subsequent leukomalacia; with con-
genital diseases affecting the nervous system; with neuro-
logical or kidney malformations or impairment; or using 
opiates, corticosteroids, or other drugs that interfere with 
the nociceptive response were excluded. 
Human milk or sucrose was administered orally 2 mi-
nutes before ophthalmoscopy using a 3-ml needle-free 
syringe. The CG was given 0.5 ml/kg of 25% sucrose, ac-
cording to the institutional protocol, and the IG was given 
2 ml of human milk from a milk bank.
The response of the premature infants to the pain-
ful procedure was assessed according to the following 
variables: crying time, HR, and salivary cortisol concen-
tration. The facial expression was not included in the 
analysis because the ophthalmoscopic procedure preclu-
des the proper visualization of the face and thus makes 
the coding of facial gestures on images impossible. The 
following data were collected from the participants’ cli-
nical records: GA, birth weight, corrected age, postnatal 
age, and Apgar score. 
The crying time and HR were measured at three time 
points: baseline – B (5 minutes before the procedure), du-
ring ophthalmoscopy – P (procedure, which lasted 3 to 12 
minutes), and recovery – R (5 minutes after the procedu-
re). HR was measured via two cardiac electrodes placed 
on the chest of the newborn and connected to a Polar 
RS300X monitor; the corresponding data were later trans-
ferred to the Polar Training Software. Crying was identi-
fied by analyzing the images of the infants’ faces recorded 
with a camera (Sony - Digital Handcan, model DVD92) at 
the three established time points.
 To measure the salivary cortisol, saliva was collected 
before (baseline cortisol) and at 30 minutes and 60 mi-
nutes after the procedure (response and recovery corti-
sol, respectively) using a needle-free 21G scalp vein set 
connected to a 3-ml syringe, which provided the neces-
sary negative pressure to collect 0.5 ml to 1 ml of saliva. 
The samples were centrifuged and measured twice by a 
technician at the Laboratory of Endocrinology and Meta-
bolism of the hospital’s Department of Internal Medici-
ne. For this purpose, the radioimmunoassay method was 
used, and the intra- and interassay coefficients were 3.7% 
and 12.5%, respectively. 
The database was first generated on an EXCEL spre-
adsheet to encode the variables; the data were entered 
twice to ensure their reliability. After the comparison of 
these two databases and the correction of divergences, 
the data were exported to the Statistical Package for the 
Social Sciences-SPSS (version 19.0) software.
Descriptive statistics (mean and standard deviation) 
was used for the quantitative variables, and the distri-
bution of frequencies was used for the qualitative (or 
categorical) variables. The normality of the distribution 
of the average results of the quantitative variables (GA, 
birth weight, corrected age, postnatal age, Apgar score, 
duration of ophthalmoscopy, HR, salivary cortisol, and 
crying time) was assessed by the Kolmogorov-Smirnov 
test. The intergroup comparison of the distribution of 
the variable gender was performed using Fisher’s exact 
test. The intergroup comparison of the average values 
of the variables GA, birth weight, corrected age, postna-
tal age, Apgar score, and exam duration was performed 
using Student’s t-test. The intergroup comparison of the 
average values of HR, crying time, and salivary cortisol 
corresponding to the three different time points was 
performed using the repeated-measures analysis of va-
riance (RM-ANOVA). The within-subjects factor used in 
each ANOVA corresponded to the three time points of 
data collection. In the case of RM-ANOVA, the sphericity 
assumption of the variance matrix was investigated, whi-
ch is essential in this type of analysis. The significance 
level was established as 5%.
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RESULTS  
Table 1 lists the means and standard deviations of the 
variables corresponding to the participants’ birth per group, 
together with the corresponding p values. The results of 
Student’s t-test revealed that the birth weight, Apgar score, 
GA, corrected age, and postnatal age did not exhibit signifi-
cant differences between the groups. Of the 14 premature 
infants included in the study, eight were female and six were 
male; their distribution in the groups was similar (p=0.091). 
The ophthalmoscopy lasted 3 to 12 minutes and was 
longer in the IG compared with the CG (8.9±3.2 minutes 
vs. 4.3±1.5 minutes, p=0.029).
Figure 1 depicts the average HR at each investigated 
time point.
Comparison of the average HR among the three inves-
tigated time points by RM-ANOVA revealed a statistically 
significant difference [F(2,24)=17.529; p<0.005]. These re-
sults demonstrated that the participants’ average HR exhi-
bited changes along the three investigated time points, 
being higher during the procedure compared with during 
the baseline and recovery; however, the average HR did 
not exhibit significant differences between the IG and the 
CG [F(2,24)=1.876; p=0.175]. These findings indicate that, 
independent of the treatment provided, the HR did not 
vary between the groups at any investigated time point.
Comparison of the average crying time percentage 
among the investigated time points (via RM-ANOVA) re-
vealed the effect of the factor time, i.e., the crying ti-
me exhibited significant differences along the investiga-
ted time points [Wilks’ Lambda= 0.295; F(2,10)=11.992; 
p<0.005]. Thus, the average crying time percentage 
was greater at P compared with at B (p<0.001) and R 
(p<0.001). However, the crying time did not exhibit sig-
nificant differences between the IG and the CG [Wilks’ 
Lambda=0.60; F(2,10)=3.33; p=0.078]. The crying ti-
me did not exhibit a statistically significant difference 
(p=0.069) between the groups.
Figure 2 depicts the average salivary cortisol at the 
three investigated time points (B, P, and R).
Comparison of the average salivary cortisol among 
the three investigated time points (via RM-ANOVA) re-
vealed significant differences [Wilks’ Lambda=0.482; 
F(2,11)=5.903; p=0.018]. The average salivary cortisol 
response was higher than at the baseline (p=0.007); ho-
wever, there was no significant difference between the 
response and recovery salivary cortisol (p=0.982). The 
average salivary cortisol did not exhibit a significant diffe-
rence between the IG and the CG [Wilks’ Lambda=0.739; 
F(2,11)=1.947; p= 0.189].
Table 1 - Description of the neonatal characteristics - Ribeirão 
Preto, SP, Brazil, 2012
Variables
GI GC
χ– Sd χ– Sd p*
Birth weight (g) 1194,00 ± 114,204 1233,33 ± 323,574 0,800
Apgar (1 minute) 6,00 ± 2,00 7,11 ± 1,97 0, 333
Apgar (5 minutes) 8,4 ± 1,34 8,89 ± 1,17 0,489
Gestational age (days) 218,4 ± 1,14 222,33 ± 21,63 0,697
Corrected age (days) 257,6 ± 10,36 260,89 ± 11,96 0,944
Postnatal age (days) 39,2 ± 10,62 38,56 ± 18,26 0,616
IG= intervention group, CG= control group  χ–= mean  Sd= standard 
deviation *Student’s t-test  α=0.05
Table 2 – Mean and standard deviation of the crying time at each 
investigated time point per group - Ribeirão Preto, SP, Brazil, 2012
Time points                   Group               n Crying timeχ– (DP)
FB Sucrose             9 17,33 (46,1)
Milk               4 14,25 (28,5)
FP Sucrose             9 93,22 (76,6)
Milk               4 270 (188,1)
FR Sucrose             9 6,78 ( 18,8)
Milk               4 5,00 (4,9)
n= sample size; χ–= mean; SD= standard deviation 
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Figure 1 - VAverage HR values at each investigated ophthalmos-
copic time point, per group - Ribeirão Preto, SP, Brazil, 2012.
Figure 2 - Average salivary cortisol (nmol/dl) at the three investi-
gated ophthalmoscopic time points relative to ophthalmoscopy per 
group - Ribeirão Preto, SP, Brazil, 2012.
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DISCUSSION 
The main finding of the present study concerns the 
analgesic effect of human milk, which did not differ from 
the effect of sucrose during ophthalmoscopy. Indeed, hu-
man milk appears to have been as effective as sucrose for 
inducing pain relief in the investigated sample. Notably, 
the present investigation is the first to compare the effecti-
veness of human milk to sucrose during ophthalmoscopy.
In a systematic review(10), maternal milk (2 to 5 ml), 
either combined or not combined with non-nutritive su-
cking, was compared with distilled water, no treatment, 
sucrose, glucose, pacifier use, and tucking during heel and 
vein punctures in premature and full-term infants. The 
use of maternal milk was associated with lower increa-
ses of HR and pain scores (Neonatal Facial Coding System 
- NFCS) compared with the control group; however, the 
crying time and the SatO
2
 did not exhibit statistically sig-
nificant differences. The authors concluded that maternal 
milk might be used for pain relief in newborn infants, with 
effects similar to those of sucrose and glucose.
A more recent study compared the effectiveness of 2 
ml of pumped maternal milk (IG) compared with 2 ml of 
25% glucose (CG) for pain relief during heel punctures in 42 
borderline premature infants. Both solutions were adminis-
tered 2 minutes before the heel puncture was performed 
to assess the capillary blood glucose. The PIPP scores were 
lower in the CG during the first 3 minutes after the end of 
the procedure (CG: 25.6% vs. IG: 60.0%; p=0.002), although 
these scores exhibited a significant reduction in both groups 
over time (F=15.62, p=0.001). Compared with the IG, the 
CG participants exhibited a lower incidence of crying (CG: 
42.2% vs. IG: 78.6%; p=0.001) and a shorter crying time af-
ter the heel puncture (CG: 14.53% vs. IG: 32.02%; p=0.014). 
The authors concluded that single doses and small volumes 
of milk are not effective for neonatal pain relief but that 
greater volumes might yield better results(11). In contrast to 
that study, we did not use the participants’ mothers’ milk, 
in addition to using a different pain stimulus, which might 
have contributed to the divergence in the results.
Another investigation compared the effect of one dose 
(2 ml) vs. two doses of pumped maternal milk, one dose 
(2 ml) vs. two doses of 12.5% sucrose, and one dose (1 
ml) vs. two doses of distilled water in 142 full-term infants 
subjected to heel punctures. In the groups that were gi-
ven repeated doses, 2 ml of the corresponding substance 
were administered both 2 minutes prior to and imme-
diately before the procedure. The group that was given a 
single dose of sucrose exhibited the shortest crying time 
(82 seconds); however, this variable did not exhibit signi-
ficant differences among the groups (p=0.053). Similarly, 
the NFCS scores did not demonstrate statistically signifi-
cant differences among the groups (p=0.068). The authors 
concluded that two doses of sucrose or pumped maternal 
milk were not more effective than a single dose for relie-
ving the pain associated with heel punctures(17). 
The divergence among the findings relative to the 
effect of maternal milk on neonatal pain relief is evident. 
Therefore, it is necessary to conduct studies comparing 
the effectiveness of human milk vs. pumped maternal 
milk, as well as the effectiveness of different volumes of 
human milk, for providing pain relief in premature infants.
The present study also revealed that the pain indica-
tors (HR, crying time, and salivary cortisol) increased in 
both the premature infants who were given human mi-
lk and the infants who were given sucrose during ROP 
ophthalmoscopy.
Moreover, other investigators have found changes in 
the physiological and behavioral indicators that are cha-
racteristic of the global response to stress following an 
acute painful stimulus, which include (but are not limited 
to) autonomous, metabolic, and behavioral changes(18-19). 
Due to the specific nature and duration of ophthalmos-
copy, it does not seem probable that a single intervention 
might suffice to reduce the associated pain(7). Therefore, 
further clinical trials are necessary to compare the combi-
ned effect of human milk and other interventions, such as 
the kangaroo position and non-nutritive sucking.
In the present investigation, we sought to assess the 
changes in the salivary cortisol of premature infants sub-
jected to ophthalmoscopy because pain may activate the 
hypothalamic-pituitary-adrenal (HPA) axis, inducing an 
endocrine response in premature infants that manifests 
as increased cortisol levels(18). Cortisol affects the meta-
bolism, cardiovascular system, and central nervous sys-
tem(19). Salivary cortisol has been used in studies to assess 
the effects of non-pharmacological interventions against 
pain in newborn infants, including sucrose, the kangaroo 
position, and developmental care(20-22).
Only one previous study has assessed salivary corti-
sol in premature infants subjected to ophthalmoscopy. 
In that study, one group was administered NIDCAP stra-
tegies, and the other group was provided the standard 
care only. The salivary cortisol was lower 60 minutes 
after the end of the procedure (compared with 30 mi-
nutes after) in both groups; however, 4 hours later, the 
salivary cortisol was reduced in the NIDCAP group on-
ly, which indicates a greater effect of treatment on the 
premature infants’ recovery(22). By contrast, in the pre-
sent study, the salivary cortisol did not differ 30 and 60 
minutes after the end of the procedure in either group 
(i.e., treated with sucrose vs. human milk). Thus, we re-
commend that future studies investigate the long-term 
effect of human milk by measuring the salivary cortisol 2 
to 4 hours after ophthalmoscopy.
Certain limitations of the present study should be 
mentioned, such as the small sample size and the lack of 
randomization, which do not allow for extrapolating the 
results or establishing causal relationships. In addition, 
the differences in the ophthalmoscopic durations might 
have interfered with the results. This difference might 
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have been partially due to the large number of professio-
nals who assessed the infants, as the study was perfor-
med at a teaching hospital.
CONCLUSIONS
Human milk did not differ from sucrose in the pain 
relief afforded to premature infants during ophthalmos-
copy. However, further clinical trials with the appropriate 
sample power are required before human milk can be re-
commended for the pain associated with ophthalmoscopy 
performed for ROP screening as a more widely accessible 
and natural approach compared with sucrose, in addition 
to including the mothers in the care provided. 
O estudo apresenta resultados inéditos para a enferma-
The results of the present study are innovative in the nur-
sing field related to managing ophthalmoscopy-associated 
pain in premature infants. Thus, our investigation contri-
butes to increasing the quality of care provided to these 
infants and their relatives because, to improve their sur-
vival, this patient population must be extensively expo-
sed to painful procedures. Another contribution of the 
present study is the possibility of broadening the scope 
of non-pharmacological interventions relative to ophthal-
moscopy and the likelihood of including mothers as active 
participants in the care of their infants. 
Finally, our investigation facilitated further reflection 
on the nursing care provided to premature infants subjec-
ted to ophthalmoscopy. Indeed, the tasks of nurses should 
also include orienting parents or guardians via educatio-
nal strategies that increase their knowledge and enable 
them to have an active role in care as well as establishing 
comfort measures, such as NICU light and noise reduc-
tion, flexed positioning, and non-nutritive sucking.
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